| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.045 | 0.9 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.027 | 0.9 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.0074 | 0.9 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |